(24/7 MARKET NEWS) – Kintara Therapeutics, Inc. (Nasdaq: KTRA) is moving higher in this morning’s premarket.
The biopharmaceutical company, focused on the development of new solid tumor cancer therapies, is trading at $0.132, up $0.0319 (+31.87%) and closing in on the 2 million share volume mark.
It’s at the lower end of its 52-week range of $0.087 to $1.05, with its next inflection points at about 15 and 18 cents.
24/7 MARKET NEWS, INC Disclaimer
24/7 MARKET NEWS (“24/7 MN”) is dedicated to covering various underreported segments of the stock markets. Our goal is to help you to better understand these markets, but 24/7 MN is neither an investment advisor nor a financial advisor, and no information provided here is to be interpreted as a suggestion to buy or sell stocks or other investment products. All opinions, news, research, analysis, prices or other information contained on 247marketnews.com, its press releases, or other services are provided for educational purposes only and do not constitute investment advice. You are solely responsible for the investment decisions you make.